| To: richardred who wrote (4633) | 11/7/2017 9:02:40 AM | | From: The Ox | | | | Yes, a black eye but doesn't look devastating for MNTX. It also sets up a relatively perfect double top. A lot of support in the $7.50 range and below $6 could be a long term gift at this point?
 |
| | Speculating in Takeover Targets | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: richardred | 11/12/2017 9:29:36 PM | | | | | | New HSBC chairman Mark Tucker eyes American takeovers
Aimee Donnellan
November 12 2017, 12:01am, The Sunday TimesHSBC has a troubled past in US acquisitions, but its chairman maintains an ‘optimistic view’ of future expansion
HSBC’s new chairman Mark Tucker has told investors that he is on the prowl for acquisitions, with American credit card businesses among his targets.
thetimes.co.uk |
| | Speculating in Takeover Targets | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: richardred who wrote (2863) | 11/20/2017 10:29:48 AM | | From: richardred | | | | MRVL buying CAVM for $40 cash plus 2.1757 share. Mr McWilliams was spot on. SNIP> In his special report, McWilliams discussed eight of the companies he thinks are most likely to show an interest in Cavium. These include Marvell Technology (NASDAQ: MRVL
|
| | Speculating in Takeover Targets | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: richardred who wrote (4429) | 11/20/2017 10:45:05 AM | | From: richardred | | | | | RE- RELY filed chapter 11 last Fri. I will be taking two lumps with my JVA. Most chapter 11's these days have nothing left for shareholders after re-organization? I'm just guessing this one might stand a chance. Holding to zero or whatever upside might be in the future. |
| | Speculating in Takeover Targets | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (1) |
|
| To: richardred who wrote (4632) | 11/24/2017 5:47:51 PM | | From: richardred | | | | Alibaba continues to increase its “bricks & mortar” presence
21 November 2017
In June this year when Amazon announced its $13.7bn offer for Whole Foods, there was a lot of media comment about the deal finally representing a move towards “physical” locations, as well as being an e-retailer, and many commentators seemed transfixed by this.
However, what seemed to go relatively unnoticed was the fact there is already a precedent of a global e-retailer looking to physical locations in order to help it fulfil the next stage of its strategic plan. Alibaba, the Chinese e-commerce conglomerate, had already started to invest in “bricks and mortar” retailers as far back as 2014, and yesterday saw it continue with this strategy with the announcement of its acquisition of a 26% stake in Sun Art Retail Group, the Hong Kong-based hypermarket operator.
For Alibaba, this deal represents its fourth acquisition of a “physical” retailer, after acquiring the remaining 53% of Intime Retail earlier this year, as well as minority positions in household appliance retailer Suning Commerce and Lianhua Supermarkets in May 2016 and May 2017, respectively.
The underlying driver for both Amazon and Alibaba in making these acquisitions is to access data held by the target companies, and also to bring together the two worlds of online and offline commerce for all parties involved.
Alibaba’s CEO, Daniel Zhang, is quoted as saying that “physical stores serve an indispensable role during the consumer journey, and should be enhanced through data-driven technology and personalized services in the digital economy”. He also said: “By fully integrating online and physical channels together with our partners, we look forward to delivering an original and delightful shopping experience to Chinese consumers.”
mandaportal.com |
| | Speculating in Takeover Targets | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: richardred who wrote (4614) | 11/24/2017 5:54:23 PM | | From: richardred | | | | Shanghai Pharmaceuticals to purchase Cardinal Health’s unit Shanghai Pharmaceuticals Holding is acquiring Malaysia-incorporated Cardinal Health L (Cardinal Malaysia) for USD 1,200 billion, subject to further adjustments based on the target’s working capital, existing cash and assumed debt. The buyer has obtained financing from third party financial institutions and is making the purchase via its Shanghai Pharma Century Global arm. Pending approval from China’s Ministry of Commerce, the deal is expected to complete by the end of Cardinal Health’s fiscal year.
The target is a holding unit which controls all of the China-based business of Cardinal Health, a New York Stock Exchange-listed pharmaceutical supplier. Billed as a global and integrated healthcare services provider, the Dublin and Ohio-headquartered group operates through five segments: pharmaceutical distribution, medical devices distribution, hospital direct sales, speciality pharmaceuticals and speciality pharmacies and commercial technology.
Cardinal Health currently serves almost 11,000 medical institutions and other downstream customers through 30 direct-to-patient pharmacies, 14 direct sales companies and 17 distribution centres in China. It provides drugs, medical devices, surgical supplies, speciality pharmaceuticals, vaccines and diagnostic systems and equipment in major cities ranging from Beijing and Tianjin to Dalian and Wuxi. In all, the business owns a storage area of about 146,000 square metres and 7,000 square metres of cold storage capacity.
Cardinal Malaysia posted operating revenue of CNY 25,518 million (USD 3,848 million) and earnings before interest, tax, depreciation and amortisation of CNY 553 million in H1 2017. It also had total and net assets of CNY 12,890 million and CNY 1,909 million, respectively, as of 30th June 2017.
The announcement comes as China is planning a reform to tighten oversight of its fragmented healthcare industry, a move that could significantly slow Cardinal Health’s business growth. An unnamed person familiar with the matter previously told Reuters: “The new policy is likely to squeeze margins for most distributors in China. They will be under pressure for future profitability. It does make Cardinal and others worried.”
From Shanghai Pharmaceuticals’ perspective, the deal serves to widen its distribution network, particularly in Shanghai, Beijing, Zhejiang, Tianjin and Chongqing, among other locations. Commenting on the transaction, the buyer’s chairman Zhou Jun said: “Amid the national healthcare reform, the acquisition of the Cardinal Health China business will further strengthen our leadership in the distribution and retail pharmacy network, and expedite our transformation to become a modern global healthcare provider.”
Last July, Cardinal Health successfully carried out its largest deal on record to buy the medical supplies businesses of Medtronic for USD 6,100 million. In a much smaller transaction early this year, Cardinal Health purchased 6 per cent of Navidea Biopharmaceuticals, an Ohio-based diagnostics and radiopharmaceutical medical products maker, for around USD 7 million.
© Zephyr
mandaportal.com |
| | Speculating in Takeover Targets | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: richardred who wrote (4633) | 11/24/2017 5:58:45 PM | | From: richardred | | | | MNTX-speculation
M-L Holdings Company Crane Group Acquires Chellino Crane
Post date:
11/08/2017 - 10:31am
M-L Holdings Company Crane Group announced that is has acquired Chellino Crane, a premier crane services company in the Chicagoland area. Founded in 1947 by Sam Chellino, the company has grown to become one of the largest crane companies in the Midwest.
We are excited to add such a great company to our existing network of crane branches.” said Scott Wilson, president of M-L Holdings Company Crane Group. “The acquisition of Chellino Crane extends our reach across the Midwest, allowing our combined customer base to access additional resources quickly and efficiently. The Chellino family and M-L Holdings Company Crane Group will continue to provide the same great service and support customers have grown to value over the years.”
With the addition of Chellino Crane, M-L Holdings Company Crane Group has increased their crane service fleet to a total of 14 full-service branch locations supplying 427 employees, 265 cranes with sizes ranging from 600 tons to 8.5 tons, 475 trailers, 310 road tractors and 75 forklifts.
At M-L Holdings Company Crane Group, we continue to exceed the needs of our current and future customers, providing Nationwide Reach and Local Support.
liftandaccess.com |
| | Speculating in Takeover Targets | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (1) |
|
| To: richardred who wrote (4641) | 11/24/2017 6:18:27 PM | | From: richardred | | | | Woolston Group targets £50m in revenue after making its first acquisition
Published: 05:40 Wednesday 01 November 2017
Yorkshire-based Ward Woolston Group has acquired LDH Plant Limited as it aims to build one of the UK’s largest capital equipment dealers in the construction, demolition and waste management sectors. The group, based in Northallerton and the owner of Londonderry Garage Specialist Equipment (LGSE), is now targeting a revenue of more than £50m in the next five years. Established just two years ago, Ward Woolston Group is currently the largest supplier of Hiab truck mounted cranes and multilift demountable equipment in the UK. The company employs 60 people engaged in the sale of new and used machinery, parts and repair services to customers in the public and private sector, Led by managing director Scott Woolston, who co-owns the group with chairman Michael Ward, the business has grown substantially, with revenue increasing from £6 million in 2015 to £10 million in 2017. LDH Plant Limited is a construction equipment supplier based in Newport, Wales with more than 20 years trading experience. Robert Vaughan, the former managing director of LDH Plant, will remain with the business as sales director and Nicholas Higgins will retain the role of operations director. Ear Cancer in Cats Promoted by petmd [Opt out of Adyoulike ad targeting] Mr Woolston said: “LDH Plant is a well-established company, founded on like-minded principles and a strong culture of client care, which will complement and strengthen our services across the UK and create a business with combined revenue of £16 million.” Legal adviser to the Ward Woolston Group was a team from Squire Patton Boggs, led by Corporate partner Paul Mann and associate Maxine Burton.
Read more at: yorkshirepost.co.uk |
| | Speculating in Takeover Targets | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |
